Navigation Links
Study examines the effect of epilepsy on the aging
Date:4/16/2008

Madison, Wis. April 16, 2008 An article published in the May 2008 issue of Epilepsia calls attention to the lack of knowledge regarding cognitive aging in chronic epilepsy patients. For persons with chronic epilepsy, little is known about the impact of aging on the course of cognitive and brain health, the prevalence of clinical disorders of aging (mild cognitive impairment, dementia), or the disease burdens and risk factors associated with abnormal cognitive and brain aging. The study presents data that suggest several reasons for concern.

Numerous cognitive deficits, neuroimaging abnormalities and psychiatric comorbidities have been well characterized in younger persons with chronic epilepsy, with evidence of progression of these problems in some patients by middle age. People with chronic epilepsy have been exposed to several influences that may place them at increased risk for accelerated cognitive and brain aging, including: treatment with medications now known to adversely affect cholesterol, folate and glucose metabolism; increased rates of vascular disease risk factors; altered lifestyles that include decreased social interaction and physical inactivity; and elevated inflammatory markers.

The cognitive status of persons who have lived with epilepsy for a long time is unclear, says Bruce P. Hermann, lead author of the study. Because persons with epilepsy carry other risk factors for abnormal cognitive and brain aging, there should be great concern regarding the lack of knowledge about their cognitive and brain status in older years.

Previous research has identified numerous risk factors for abnormal cognitive aging and dementia in the general population, including vascular, inflammatory and lifestyle factors. Many of these factors are overrepresented in epilepsy, but not examined in relationship to cognitive and brain aging in epilepsy. This oversight is important given the epidemiological evidence that risk exposure and cog
'/>"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Study shows pine bark naturally reduces osteoarthritis
2. Study Shows Pine Bark Naturally Reduces Osteoarthritis
3. Study suggests too much screen time and not enough physical activity may lead to childhood obesity
4. St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia
5. UAB study shows investigational drug may treat biliary cancers
6. Study shows that high-dose, high-frequency interferon produces no additional benefit
7. Study finds media coverage of breast cancer focuses too little on prevention
8. USC study finds evidence of gender-related differences in development of colon cancer
9. New study in JCSM finds that obesity can predict upper airway obstruction amongst children
10. Study shows increase of hip and knee replacements in the US
11. Study shows decline in work disability due to rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... NEW ORLEANS, Dec. 7 Cell Therapeutics, ... that Ruth Pettengell, M.D. of St. George,s Hospital, ... 2009 American Society of Hematology ("ASH") Annual Meeting ... (PIX 301) clinical trial of pixantrone (the "PIX ... non-Hodgkin,s lymphoma ("NHL") patients who have failed ...
(Date:12/6/2009)... OAK BROOK, Ill., Dec. 7 The ... center (AMC) members for their achievements in UHC,s ... 10 organizations are noted for modeling best practices ... (Photo: http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were ... calculation that includes contract portfolio participation and use ...
(Date:12/6/2009)... discovered that the loss of a key segment of DNA ... study to show that this kind of genetic alteration can ... . , The study, led by Dr Sadaf Farooqi from ... Wellcome Trust Sanger Institute, looked at 300 children with severe ... for types of mutation known as copy number variants (CNVs). ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Onyx Pharmaceuticals, Inc. ... data from the pivotal Phase 2b 003-A1 study, ... is well-tolerated in heavily pre-treated relapsed and refractory ... at the ASH/ASCO Joint Symposium at the 51st ... (ASH) in New Orleans. Enrollment in this trial ...
(Date:12/6/2009)... www.sleeping-with-a-sleeping-disorder.com is asking people ,who have ... aids from around the world to donate their ... submissions will be compiled in an ebook titled ... be sold from the website in early January ... proceeds ,from sales of the E-book to three ...
Breaking Medicine News(10 mins):Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... SHENZHEN, China, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- China Display,Technologies, ... "the,Company"), a leading manufacturer of optoelectronic products, specializing,in ... for LCD displays in,China, today announced its Vice ... Officer, Mr. Kam Ming Yip will present at ...
... of genes that prevent cell death in those with ... Researchers from Saint Louis University report that a pile-up ... finding which could point to new therapies for the ... finding new treatments for lupus," said Dr. Jill Buyon, ...
... nomination campaign, some candidates health care plans have been ... has been used to attack health reform proposals in ... Opinion Research Program at the Harvard School of Public ... split on whether a socialized medical system would be ...
... 14 Workplace stress is the,most frequently cited ... acknowledge that stress is affecting business performance,few are ... surveys by Watson,Wyatt Worldwide, a leading global consulting ... percent) say stress caused by working,long hours is ...
... Officials at,Southern Research Institute today announced that Wilson ... has been named Vice,President of its Drug Discovery ... "We are very pleased that Dr. Knight has ... research program," said John A. "Jack" Secrist,III, Ph.D., ...
... WASHINGTON, Feb. 14 Lung Cancer Alliance,announced today ... joined its Board of Directors., LCA Board ... the,following statement:, "Secretary Mineta,s remarkable career in ... leadership on national security, transportation,infrastructure and technology issues ...
Other Medicine News:Health News:China Display Technologies, Inc. to Present at Roth Conference 2Health News:China Display Technologies, Inc. to Present at Roth Conference 3Health News:Overabundance of Immune Cells Might Trigger Lupus 2Health News:Overabundance of Immune Cells Might Trigger Lupus 3Health News:Poll finds Americans split by political party over views on socialized medicine 2Health News:Poll finds Americans split by political party over views on socialized medicine 3Health News:Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find 2Health News:Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find 3Health News:Southern Research Institute Names Blaine Knight Vice President of Drug Discovery 2Health News:Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors 2
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... Ill., Dec. 4 Hospira, Inc. (NYSE: ... delivery company, today announced the launch of its next-generation ... (I.V.) medications and solutions, and now offers a complete ... award-winning, environmentally responsible VisIV product. The launch of the ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2More Ontario children are getting diagnosed with diabetes 3A ICES study 48205 1Common chemotherapy drug triggers fatal allergic reactions 8748 1Common chemotherapy drug triggers fatal allergic reactions 8748 2Common chemotherapy drug triggers fatal allergic reactions 8748 3
... The Acclaim 7000 Nd:YAG laser ... by offering cosmetic procedures such as ... facial veins, our Dermique LaserFACIAL for ... offers selectable parameters for customizing treatment ...
... laser beam is delivered through an ultra thin ... the operator full freedom of movement when performing ... with a wide range of handpieces. Handpieces ... mm and 16 mm. Straight and angled ...
VERSASTEP™ Reposable Reusable Components (Standard Length)....
VERSASTEP™ Reposable Single Use Trocar For use with VERSASTEP™ Reusable Cannula, Dilator....
Medicine Products: